Related references
Note: Only part of the references are listed.Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial
Michael Friedlander et al.
LANCET ONCOLOGY (2021)
Quality-adjusted time without symptom or toxicity (QA-TWiST) and quality-adjusted progression-free survival (QA-PFS) of first-line (1L) maintenance niraparib in patients with advanced ovarian cancer (OC): Results from the PRIMA trial
M-P. Barretina-Ginesta et al.
ANNALS OF ONCOLOGY (2021)
Association Between the Use of Surrogate Measures in Pivotal Trials and Health Technology Assessment Decisions: A Retrospective Analysis of NICE and CADTH Reviews of Cancer Drugs
Ashlyn Pinto et al.
VALUE IN HEALTH (2020)
Measuring Quality of Life in Ovarian Cancer Clinical Trials-Can We Improve Objectivity and Cross Trial Comparisons?
Gita Bhat et al.
CANCERS (2020)
Association of Disease Progression With Health-Related Quality of Life Among Adults With Breast, Lung, Pancreatic, and Colorectal Cancer
Norbert Marschner et al.
JAMA NETWORK OPEN (2020)
Ovarian Cancer: An Integrated Review
Christine Stewart et al.
SEMINARS IN ONCOLOGY NURSING (2019)
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
A. Gonzalez-Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Real-world adverse events with niraparib 200 mg/day maintenance therapy in ovarian cancer: a retrospective study
Jack R. Gallagher et al.
FUTURE ONCOLOGY (2019)
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
K. Moore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy
M. Friedlander et al.
ANNALS OF ONCOLOGY (2018)
Impact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future
Nicoletta Colombo et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Health-related quality of life in ovarian cancer patients and its impact on clinical management
Dana M. Chase et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2011)
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
A. Simon Pickard et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2007)
A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation
BL Conner-Spady et al.
BONE MARROW TRANSPLANTATION (2005)
An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer
E Greimel et al.
EUROPEAN JOURNAL OF CANCER (2003)
Anxiety disorders in cancer patients: Their nature, associations, and relation to quality of life
D Stark et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
